Avient vs Celanese
AVNT and CE side by side, both in chemicals and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How AVNT and CE compare
Celanese is the larger company, worth 1.3 times as much as Avient ($5.6B against $4.2B).
Avient grew revenue faster over the last twelve months (5.2% versus −2.2% for Celanese).
Avient keeps more of each dollar of sales as profit, with a net margin of 5.3% compared with −12.0% at Celanese.
Both pay dividends: Avient yields 2.4% and Celanese 0.17%.
Avient scores higher on the StockData Score (13 against 7 for Celanese), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | AVNT | CE |
|---|---|---|
| Size and price | ||
| Market cap | $4.2B | $5.6B |
| Share price | $46.23 | $51.45 |
| Change, 1 year | 56.0% | 24.6% |
| Change, 5 years | −23.0% | −69.0% |
| Beta (5Y) | 1.34 | 1.12 |
| Employees | 9,000 | 11K |
| StockData Score | ||
| Total score | 13 (better) | 7 |
| Valuation score | 3 | 3 |
| Growth score | 2 (better) | 1 |
| Performance score | 2 (better) | 0 |
| Health score | 2 (better) | 1 |
| Dividend score | 4 (better) | 2 |
| Valuation | ||
| P/E | 23.7× | – |
| P/S | 1.2× | 0.6× (better) |
| P/B | 1.7× | 1.4× (better) |
| EV/EBITDA | 10.8× (better) | 117× |
| P/FCF | 17.7× | 8.0× (better) |
| FCF yield | 5.6% | 12.5% (better) |
| Fair value | $54.10 | $87.24 |
| Margin of safety | 14.5% | 41.0% (better) |
| Growth | ||
| Revenue growth (TTM) | 5.2% (better) | −2.2% |
| Revenue growth, 5Y average | 8.0% | 11.0% (better) |
| Net income growth (TTM) | 59.0% | – |
| EPS growth (TTM) | 57.3% | – |
| EPS growth, 5Y average | −9.3% | – |
| Profitability | ||
| Gross margin | 31.7% (better) | 20.9% |
| Operating margin | 9.7% (better) | −7.1% |
| Net margin | 5.3% (better) | −12.0% |
| FCF margin | 7.0% | 7.3% (better) |
| Return on equity | 7.5% (better) | −24.8% |
| Return on invested capital | 6.4% (better) | −3.4% |
| Financial health | ||
| Debt / equity | 0.74 (better) | 2.88 |
| Net debt / EBITDA | 2.65 (better) | 74.43 |
| Interest coverage | – | −1.0× |
| Current ratio | 1.71 (better) | 1.45 |
| Altman Z-score | 1.62 (better) | 1.31 |
| Piotroski F-score | 6 (better) | 5 |
| Dividends and buybacks | ||
| Dividend yield | 2.4% (better) | 0.17% |
| Payout ratio | 55.7% | – |
| Years of dividend growth | 15 | – |
| Dividend growth, 5Y average | 5.8% | – |
| Shareholder yield | 2.4% (better) | 0.17% |
| Ownership | ||
| Held by institutions | 105% | 111% |
| Held by insiders | 0.83% | 0.41% |
| Insider net buying, 12 months | – | $593K |
| Short interest, % of float | 4.7% | 5.6% |
Go deeper
- AVNT stock overview
- AVNT income statement
- AVNT valuation and score
- CE stock overview
- CE income statement
- CE valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.